AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Rocket Pharmaceuticals In... (RCKT)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

10.79

0.36 (3.45%)

At close: Jan 15, 2025, 11:21 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	7.10M	6.27M	5.37M	1.15M	426.00K	330.00K	204.00K	169.00K	45.00K	n/a	n/a	n/a
Gross Profit	-7.10M	-6.27M	-5.37M	-1.15M	-426.00K	-330.00K	-204.00K	-169.00K	-45.00K	n/a	n/a	n/a
Operating Income	-259.66M	-224.34M	-167.25M	-134.30M	-76.15M	-71.16M	-26.74M	-41.88M	-20.40M	-7.70M	-6.65M	-5.85M
Interest Income	15.94M	3.89M	3.07M	2.15M	3.41M	1.69M	819.00K	443.00K	89.00K	n/a	n/a	n/a
Pretax Income	-245.59M	-221.86M	-169.07M	-139.70M	-77.27M	-74.52M	-29.50M	-42.85M	-67.98M	-9.53M	-7.62M	-6.06M
Net Income	-245.59M	-219.38M	-169.59M	-146.67M	-83.23M	-74.52M	-29.50M	-42.85M	-67.98M	-9.53M	-7.62M	-6.06M
Selling & General & Admin	73.32M	58.77M	41.77M	27.92M	17.53M	17.89M	12.54M	9.89M	7.84M	2.11M	1.32M	2.31M
Research & Development	180.97M	165.57M	125.48M	106.38M	58.62M	53.27M	14.19M	31.98M	12.55M	5.59M	5.33M	3.54M
Other Expenses	n/a	-500.00K	-1.00M	n/a	-250.00K	186.00K	n/a	n/a	n/a	n/a	3.00K	4.00K
Operating Expenses	259.66M	223.84M	166.25M	134.30M	75.90M	70.97M	26.74M	41.88M	20.40M	7.70M	6.65M	5.85M
Interest Expense	1.88M	1.91M	5.89M	7.55M	4.78M	5.24M	3.58M	1.42M	1.23M	980.00K	884.00K	213.00K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	259.66M	223.84M	166.25M	134.30M	75.90M	70.97M	26.74M	41.88M	20.40M	7.70M	6.65M	5.85M
Income Tax	n/a	-2.48M	516.00K	6.97M	5.96M	2.68M	819.00K	443.00K	1.23M	n/a	884.00K	217.00K
Shares Outstanding (Basic)	84.01M	68.15M	63.24M	55.38M	49.01M	39.38M	6.77M	6.68M	4.58M	3.42M	2.10M	2.10M
Shares Outstanding (Diluted)	84.01M	68.15M	63.24M	55.38M	49.01M	39.38M	6.77M	6.68M	4.58M	3.42M	2.10M	2.10M
EPS (Basic)	-2.92	-3.22	-2.68	-2.65	-1.7	-1.89	-4.36	-6.41	-14.85	-2.79	-3.62	-2.88
EPS (Diluted)	-2.92	-3.22	-2.68	-2.65	-1.7	-1.89	-4.36	-6.41	-14.85	-2.79	-3.62	-2.88
EBITDA	-236.62M	-213.69M	-161.72M	-131.59M	-71.14M	-71.16M	-26.74M	-41.27M	-20.26M	-7.70M	-6.73M	-5.84M
Depreciation & Amortization	7.10M	6.27M	5.37M	1.15M	426.00K	330.00K	204.00K	169.00K	45.00K	n/a	3.00K	9.00K